Endocrinology, Diabetes, and Metabolism· Topic 4.2 Thyroid disorders· 4.2.2

Graves disease

Graves disease is an autoimmune disorder in which thyrotropin receptor antibodies stimulate the thyroid, causing hyperthyroidism, and is the most common cause of thyrotoxicosis in iodine-sufficient regions. Diagnosis rests on a suppressed thyroid-stimulating hormone with elevated free thyroxine and positive thyrotropin receptor antibodies, and first-line treatment is a thionamide, most often methimazole, with radioactive iodine or thyroidectomy reserved for recurrence or patient preference.

14 min read8 practice questions8 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    Autoimmune thyroid stimulation: Graves disease is an autoimmune disorder in which T lymphocytes become sensitized to thyroid antigens and drive B lymphocytes to produce thyrotropin (TSH) receptor…

  • Epidemiology

    Most common cause of thyrotoxicosis: hyperthyroidism affects about 1.3% of the United States population, and Graves disease is the dominant cause in iodine-replete regions.

  • Risk factors

    Family history of thyroid autoimmunity: clusters in families, paralleling the risk pattern seen with Hashimoto thyroiditis.

  • Pathophysiology

    TRAb activates the TSH receptor: stimulating antibodies bind the TSH receptor on thyroid follicular cells, driving continuous hormone synthesis and release independent of pituitary feedback.

  • Clinical features

    Biochemical thyrotoxicosis with a diffusely enlarged gland: the thyroid is diffusely enlarged, may have a bruit, and has a firm, smooth texture; cervical lymphadenopathy can also occur.

  • Differential diagnosis

    Toxic multinodular goiter: autonomously functioning thyroid tissue in an asymmetric, nodular gland, unlike the diffusely smooth gland of Graves disease, and TRAb is negative.

  • Diagnosis

    The diagnosis is established biochemically and immunologically: a suppressed TSH with elevated free T4 or total/free triiodothyronine (T3) confirms thyrotoxicosis, and a positive TRAb (TSI) test…

  • Management

    First, confirm the diagnosis and start a thionamide.

  • Complications

    Thyroid storm: a life-threatening exacerbation of thyrotoxicosis, often precipitated by infection, surgery, trauma, or abrupt thionamide discontinuation, presenting with fever, tachyarrhythmia, and…

  • Prognosis

    Good with appropriate treatment: most patients achieve euthyroidism with thionamide therapy, definitive ablation, or surgery.

  • Prevention

    Smoking cessation reduces the risk and severity of Graves ophthalmopathy, the single most modifiable risk factor identified for this complication.

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.